Skip to main content
Back
ORPEF logo

Orpea S.A.

Data quality: 100%
Overbought
ORPEF
OTC Healthcare Medical - Care Facilities
$14.22
$0.00 (0.00%)
Mkt Cap: 2.29B
Day Range
$0.01 $14.22
52-Week Range
$0.01 $14.22
Volume
1,479
50D / 200D Avg
$14.22 / $14.22
Prev Close
$14.22

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -5.6 0.4
P/B 1.3 2.9
ROE % -22.8 3.8
Net Margin % -7.3 3.9
Rev Growth 5Y % 9.5 10.0
D/E 5.1 0.2

Key Takeaways

Revenue grew 9.48% annually over 5 years — modest growth
Earnings declined -130.41% over the past year
Debt/Equity of 5.14 — high leverage
Generating 328.61M in free cash flow
PEG of 0.05 suggests growth is underpriced
Capital efficient — spends only 2.55% of revenue on capex

Growth

Revenue Growth (5Y)
9.48%
Revenue (1Y)8.42%
Earnings (1Y)-130.41%
FCF Growth (3Y)14.42%

Quality

Return on Equity
-22.82%
ROIC-0.27%
Net Margin-7.31%
Op. Margin-0.68%

Safety

Debt / Equity
5.14
Current Ratio0.72
Interest Coverage-0.10

Valuation

P/E Ratio
-5.57
P/B Ratio1.33
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8.42% Revenue Growth (3Y) 9.73%
Earnings Growth (1Y) -130.41% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 9.48% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5.64B Net Income (TTM) -412.07M
ROE -22.82% ROA -3.07%
Gross Margin 80.01% Operating Margin -0.68%
Net Margin -7.31% Free Cash Flow (TTM) 328.61M
ROIC -0.27% FCF Growth (3Y) 14.42%
Safety
Debt / Equity 5.14 Current Ratio 0.72
Interest Coverage -0.10 Dividend Yield 0.00%
Valuation
P/E Ratio -5.57 P/B Ratio 1.33
P/S Ratio 0.41 PEG Ratio 0.05
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 2.29B Enterprise Value 10.63B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 5.64B 5.20B 4.68B 4.30B 3.92B
Net Income -412.07M 1.35B -4.03B 65.19M 160.05M
EPS (Diluted) -2.62 652.97 -3116.52 47.68 117.17
Gross Profit 4.51B 655.93M -91.39M 277.71M 459.68M
Operating Income -38.20M -918.73M -664.29M 364.61M 426.42M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 13.41B 13.91B 14.49B 17.07B 16.97B
Total Liabilities 11.69B 12.02B 16.00B 14.74B 13.48B
Shareholders' Equity 1.72B 1.89B -1.50B 2.32B 3.50B
Total Debt 8.86B 9.16B 13.38B 12.13B 10.53B
Cash & Equivalents 518.72M 644.95M 856.42M 952.37M 888.84M
Current Assets 1.88B 2.37B 1.91B 2.42B 1.86B
Current Liabilities 2.62B 3.12B 9.96B 3.54B 2.63B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#339 of 616
33

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026